table of content
1 Study Coverage
1.1 Chronic Urticaria Or Hives Drug Product Introduction
1.2 Global Chronic Urticaria Or Hives Drug Outlook 2017 VS 2022 VS 2028
1.2.1 Global Chronic Urticaria Or Hives Drug Sales in US$ Million for the Year 2017-2028
1.2.2 Global Chronic Urticaria Or Hives Drug Sales in Volume for the Year 2017-2028
1.3 United States Chronic Urticaria Or Hives Drug Outlook 2017 VS 2022 VS 2028
1.3.1 United States Chronic Urticaria Or Hives Drug Sales in US$ Million for the Year 2017-2028
1.3.2 United States Chronic Urticaria Or Hives Drug Sales in Volume for the Year 2017-2028
1.4 Chronic Urticaria Or Hives Drug Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Chronic Urticaria Or Hives Drug in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Chronic Urticaria Or Hives Drug Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Chronic Urticaria Or Hives Drug Market Dynamics
1.5.1 Chronic Urticaria Or Hives Drug Industry Trends
1.5.2 Chronic Urticaria Or Hives Drug Market Drivers
1.5.3 Chronic Urticaria Or Hives Drug Market Challenges
1.5.4 Chronic Urticaria Or Hives Drug Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Chronic Urticaria Or Hives Drug Market Segment by Type
2.1.1 GDC-0853
2.1.2 GSK-2646264
2.1.3 BF-Derm-1
2.1.4 Bilastine
2.1.5 Others
2.2 Global Chronic Urticaria Or Hives Drug Market Size by Type
2.2.1 Global Chronic Urticaria Or Hives Drug Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Chronic Urticaria Or Hives Drug Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Chronic Urticaria Or Hives Drug Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Chronic Urticaria Or Hives Drug Market Size by Type
2.3.1 United States Chronic Urticaria Or Hives Drug Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Chronic Urticaria Or Hives Drug Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Chronic Urticaria Or Hives Drug Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Chronic Urticaria Or Hives Drug Market Segment by Application
3.1.1 Clinic
3.1.2 Hospital
3.1.3 Others
3.2 Global Chronic Urticaria Or Hives Drug Market Size by Application
3.2.1 Global Chronic Urticaria Or Hives Drug Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Chronic Urticaria Or Hives Drug Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Chronic Urticaria Or Hives Drug Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Chronic Urticaria Or Hives Drug Market Size by Application
3.3.1 United States Chronic Urticaria Or Hives Drug Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Chronic Urticaria Or Hives Drug Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Chronic Urticaria Or Hives Drug Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Chronic Urticaria Or Hives Drug Competitor Landscape by Company
4.1 Global Chronic Urticaria Or Hives Drug Market Size by Company
4.1.1 Top Global Chronic Urticaria Or Hives Drug Manufacturers Ranked by Revenue (2021)
4.1.2 Global Chronic Urticaria Or Hives Drug Revenue by Manufacturer (2017-2022)
4.1.3 Global Chronic Urticaria Or Hives Drug Sales by Manufacturer (2017-2022)
4.1.4 Global Chronic Urticaria Or Hives Drug Price by Manufacturer (2017-2022)
4.2 Global Chronic Urticaria Or Hives Drug Concentration Ratio (CR)
4.2.1 Chronic Urticaria Or Hives Drug Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Chronic Urticaria Or Hives Drug in 2021
4.2.3 Global Chronic Urticaria Or Hives Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Chronic Urticaria Or Hives Drug Manufacturing Base Distribution, Product Type
4.3.1 Global Chronic Urticaria Or Hives Drug Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Chronic Urticaria Or Hives Drug Product Type
4.3.3 Date of International Manufacturers Enter into Chronic Urticaria Or Hives Drug Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Chronic Urticaria Or Hives Drug Market Size by Company
4.5.1 Top Chronic Urticaria Or Hives Drug Players in United States, Ranked by Revenue (2021)
4.5.2 United States Chronic Urticaria Or Hives Drug Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Chronic Urticaria Or Hives Drug Sales by Players (2020, 2021 & 2022)
5 Global Chronic Urticaria Or Hives Drug Market Size by Region
5.1 Global Chronic Urticaria Or Hives Drug Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Chronic Urticaria Or Hives Drug Market Size in Volume by Region (2017-2028)
5.2.1 Global Chronic Urticaria Or Hives Drug Sales in Volume by Region: 2017-2022
5.2.2 Global Chronic Urticaria Or Hives Drug Sales in Volume Forecast by Region (2023-2028)
5.3 Global Chronic Urticaria Or Hives Drug Market Size in Value by Region (2017-2028)
5.3.1 Global Chronic Urticaria Or Hives Drug Sales in Value by Region: 2017-2022
5.3.2 Global Chronic Urticaria Or Hives Drug Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Chronic Urticaria Or Hives Drug Market Size YoY Growth 2017-2028
6.1.2 North America Chronic Urticaria Or Hives Drug Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Chronic Urticaria Or Hives Drug Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Chronic Urticaria Or Hives Drug Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Chronic Urticaria Or Hives Drug Market Size YoY Growth 2017-2028
6.3.2 Europe Chronic Urticaria Or Hives Drug Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Chronic Urticaria Or Hives Drug Market Size YoY Growth 2017-2028
6.4.2 Latin America Chronic Urticaria Or Hives Drug Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Chronic Urticaria Or Hives Drug Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Chronic Urticaria Or Hives Drug Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 AstraZeneca Plc
7.1.1 AstraZeneca Plc Corporation Information
7.1.2 AstraZeneca Plc Description and Business Overview
7.1.3 AstraZeneca Plc Chronic Urticaria Or Hives Drug Sales, Revenue and Gross Margin (2017-2022)
7.1.4 AstraZeneca Plc Chronic Urticaria Or Hives Drug Products Offered
7.1.5 AstraZeneca Plc Recent Development
7.2 Biofrontera AG
7.2.1 Biofrontera AG Corporation Information
7.2.2 Biofrontera AG Description and Business Overview
7.2.3 Biofrontera AG Chronic Urticaria Or Hives Drug Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Biofrontera AG Chronic Urticaria Or Hives Drug Products Offered
7.2.5 Biofrontera AG Recent Development
7.3 ELORAC, Inc.
7.3.1 ELORAC, Inc. Corporation Information
7.3.2 ELORAC, Inc. Description and Business Overview
7.3.3 ELORAC, Inc. Chronic Urticaria Or Hives Drug Sales, Revenue and Gross Margin (2017-2022)
7.3.4 ELORAC, Inc. Chronic Urticaria Or Hives Drug Products Offered
7.3.5 ELORAC, Inc. Recent Development
7.4 Faes Farma, SA
7.4.1 Faes Farma, SA Corporation Information
7.4.2 Faes Farma, SA Description and Business Overview
7.4.3 Faes Farma, SA Chronic Urticaria Or Hives Drug Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Faes Farma, SA Chronic Urticaria Or Hives Drug Products Offered
7.4.5 Faes Farma, SA Recent Development
7.5 Genentech, Inc.
7.5.1 Genentech, Inc. Corporation Information
7.5.2 Genentech, Inc. Description and Business Overview
7.5.3 Genentech, Inc. Chronic Urticaria Or Hives Drug Sales, Revenue and Gross Margin (2017-2022)
7.5.4 Genentech, Inc. Chronic Urticaria Or Hives Drug Products Offered
7.5.5 Genentech, Inc. Recent Development
7.6 GlaxoSmithKline Plc
7.6.1 GlaxoSmithKline Plc Corporation Information
7.6.2 GlaxoSmithKline Plc Description and Business Overview
7.6.3 GlaxoSmithKline Plc Chronic Urticaria Or Hives Drug Sales, Revenue and Gross Margin (2017-2022)
7.6.4 GlaxoSmithKline Plc Chronic Urticaria Or Hives Drug Products Offered
7.6.5 GlaxoSmithKline Plc Recent Development
7.7 J Uriach Y Compania, S.A.
7.7.1 J Uriach Y Compania, S.A. Corporation Information
7.7.2 J Uriach Y Compania, S.A. Description and Business Overview
7.7.3 J Uriach Y Compania, S.A. Chronic Urticaria Or Hives Drug Sales, Revenue and Gross Margin (2017-2022)
7.7.4 J Uriach Y Compania, S.A. Chronic Urticaria Or Hives Drug Products Offered
7.7.5 J Uriach Y Compania, S.A. Recent Development
7.8 Mabtech Limited
7.8.1 Mabtech Limited Corporation Information
7.8.2 Mabtech Limited Description and Business Overview
7.8.3 Mabtech Limited Chronic Urticaria Or Hives Drug Sales, Revenue and Gross Margin (2017-2022)
7.8.4 Mabtech Limited Chronic Urticaria Or Hives Drug Products Offered
7.8.5 Mabtech Limited Recent Development
7.9 Merck & Co., Inc.
7.9.1 Merck & Co., Inc. Corporation Information
7.9.2 Merck & Co., Inc. Description and Business Overview
7.9.3 Merck & Co., Inc. Chronic Urticaria Or Hives Drug Sales, Revenue and Gross Margin (2017-2022)
7.9.4 Merck & Co., Inc. Chronic Urticaria Or Hives Drug Products Offered
7.9.5 Merck & Co., Inc. Recent Development
7.10 Mycenax Biotech Inc.
7.10.1 Mycenax Biotech Inc. Corporation Information
7.10.2 Mycenax Biotech Inc. Description and Business Overview
7.10.3 Mycenax Biotech Inc. Chronic Urticaria Or Hives Drug Sales, Revenue and Gross Margin (2017-2022)
7.10.4 Mycenax Biotech Inc. Chronic Urticaria Or Hives Drug Products Offered
7.10.5 Mycenax Biotech Inc. Recent Development
7.11 Novartis AG
7.11.1 Novartis AG Corporation Information
7.11.2 Novartis AG Description and Business Overview
7.11.3 Novartis AG Chronic Urticaria Or Hives Drug Sales, Revenue and Gross Margin (2017-2022)
7.11.4 Novartis AG Chronic Urticaria Or Hives Drug Products Offered
7.11.5 Novartis AG Recent Development
7.12 Panacea Biotec Limited
7.12.1 Panacea Biotec Limited Corporation Information
7.12.2 Panacea Biotec Limited Description and Business Overview
7.12.3 Panacea Biotec Limited Chronic Urticaria Or Hives Drug Sales, Revenue and Gross Margin (2017-2022)
7.12.4 Panacea Biotec Limited Products Offered
7.12.5 Panacea Biotec Limited Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Chronic Urticaria Or Hives Drug Industry Chain Analysis
8.2 Chronic Urticaria Or Hives Drug Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Chronic Urticaria Or Hives Drug Distributors
8.3 Chronic Urticaria Or Hives Drug Production Mode & Process
8.4 Chronic Urticaria Or Hives Drug Sales and Marketing
8.4.1 Chronic Urticaria Or Hives Drug Sales Channels
8.4.2 Chronic Urticaria Or Hives Drug Distributors
8.5 Chronic Urticaria Or Hives Drug Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
